Explore the advancements in stem cell therapy for neurodegenerative diseases. Discover market size, trends, and growth projections for 2035 with a focus on treatment innovations.

Market Valued at US$ 1.69 Billion in 2024, Driven by Technological Advancements and Growing Healthcare Investments ...

Director, Paediatrics, Jaslok Hospital & Research Centre explains how stem cell therapy and regenerative medicine have the ...

Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of sickle cell gene therapy ...

Javed Shaikh, Director of RWE & HEOR, Axtria, explains how harnessing next-generation sequencing and AI-powered analytics ...

Researchers from the University of Minnesota are developing a cell therapy that would combat Alzheimer’s disease using ...

In what could be the first-of-its kind in the country, the Sher-e-Kashmir Institute of Medical Sciences (SKIMS), Soura, is ...

Cell And Gene Therapy Market Size and ForecastThe global cell and gene therapy market is projected to witness significant ...

Following CORDStrom TM, INmune Bio plans to transition production of INKmune ®, its NK-priming cell medicine for solid tumors, to the same facility, supporting ongoing and future trials in the US and ...

4, 2025 — A novel cell therapy approach using cord blood-derived ... Drug-Delivering Aptamers Target Leukemia Stem Cells for One-Two Knockout Punch Apr. 3, 2025 — Drug-carrying DNA aptamers ...

Harald Stover, Ph.D., Founder and CEO, Allarta Life Science; Professor of Chemistry and Chemical Biology, McMaster University ...

Emory University School of Medicine, US, has commenced subject enrolment for BioCardia’s Phase III CardiAMP HF II trial.